Expressions of interest sought for trade mission to UK

By Melissa Trudinger
Tuesday, 17 August, 2004

Expressions of interest are being sought from Australian biotechnology companies interested in joining a trade mission to the United Kingdom and BioPartnering Europe 2004.

The mission, which will include 15 Australian biotechnology companies, is being put together by UK Trade and Investment and Austrade, and follows on from a pilot program last year, which saw a dozen Victorian companies tour several biotech clusters in the UK.

The companies will attend a partnering program in the Scandinavian biotech cluster Medicon Valley, prior to participating in BioPartnering Europe 2004 in London from 10-12 October.

After the partnering conference, the delegates will be matched up with British companies in a special partnering session, which will also involve a number of other countries including New Zealand, France and Israel.

"Last year we took the companies all over the countryside to various biotech locations, but this year the British companies chosen to meet with the Australian delegates will come to London," said Rob Hemming, trade development manager at the British Consulate-General in Melbourne and joint leader of the Australian delegation with the BioMelbourne Network's Tim Murphy.

The cost of the mission will be borne by UK Trade and Investment, Austrade, and state governments.

"There is no direct cost for companies to participate in the program," Murphy said.

Companies interested in going should be working in one or more of the following areas: genomics, biomanufacturing, neuroscience, structural biology, metabolic disorders, agbio, medical devices, stem cells, infectious diseases, oncology, vaccines and clinical trials.

Related News

Statins reduce heart attack and stroke risk in older people

It has previously been unclear whether statins were effective in reducing heart attack and stroke...

Heart muscle regeneration genes mapped

Researchers have uncovered insights into how stem cells develop and mature into heart muscle...

The cause of 2022's mpox outbreak revealed

Researchers have discovered that the strain of mpox behind the 2022 outbreak was a weakened form...


  • All content Copyright © 2026 Westwick-Farrow Pty Ltd